Australia's Fiji Kava hits over 1-mth high on U.S. product launch

Calmer International

22/11/2022 04:33

** Shares of Fiji Kava Ltd  FIJ.AX  rise as much as 22.2% to
A$0.022, their highest since Oct. 12
    ** The medical Kava company announces listing of co's
dietary shots range across Vitamin Shoppe nationally in the
U.S., in April 2023
    ** Says Kava-based dietary shots branded as Leilo to be sold
in the U.S.
    ** Co sees biggest intraday jump since Nov. 14
    ** More than 7.86 mln shares trade hand compared to 30-day
average trading volume of 227,470 shares 
    ** Shares of co are down 76.9% YTD as of last close 
 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))